Back
Axon Enterprise, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
48
AXON
Axon Enterprise, Inc.
Last Price:
$590.89
Seasonality Move:
10.89%
Sell
41
MNPR
Monopar Therapeutics, Inc.
Last Price:
$70.68
Seasonality Move:
25.93%
Sell
48
Axon Enterprise, Inc. (AXON)
is a Sell
Is Axon Enterprise, Inc. a Buy, Sell or Hold?
-
The current Axon Enterprise, Inc. [AXON] share price is $600.19. The Score for AXON is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
AXON is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXON Stock Price Chart
What is Axon Enterprise, Inc.'s stock price today?
-
The Axon Enterprise, Inc. share price today is $600.19The current trend is relatively stagnant and AXON is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $70.92Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
AXON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.65 | Sell |
| Relative Strength Index (14 RSI): | 59.34 | Buy |
| Chaikin Money Flow: | -575014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (528.34 - 569.3) | Buy |
| Bollinger Bands (100): | (586.67 - 778.37) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.54 | Sell |
| Relative Strength Index (14 RSI): | 41.3 | Sell |
| Chaikin Money Flow: | 7856 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.72 - 85.64) | Sell |
| Bollinger Bands (100): | (46.03 - 89.35) | Buy |
AXON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 569.98 | Buy |
| 20-day SMA: | 553.54 | Buy |
| 50-day SMA: | 609.57 | Sell |
| 200-day SMA: | 678.85 | Sell |
| 8-day EMA: | 573.1 | Buy |
| 20-day EMA: | 567.56 | Buy |
| 50-day EMA: | 603.14 | Sell |
| 200-day EMA: | 644.4 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.44 | Sell |
| 20-day SMA: | 77.62 | Sell |
| 50-day SMA: | 81.13 | Sell |
| 200-day SMA: | 52.54 | Buy |
| 8-day EMA: | 71.33 | Sell |
| 20-day EMA: | 75.43 | Sell |
| 50-day EMA: | 76.56 | Sell |
| 200-day EMA: | 56.82 | Buy |
Axon Enterprise, Inc. Earnings Growth & AXON Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $1.23 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Axon Enterprise, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||